
Stellate ganglion blockade cuts menopause symptoms
(HealthDay)—For postmenopausal women, stellate ganglion blockade (SGB) significantly reduces objective measures of vasomotor symptoms (VMS), according to a study published online Feb. 3 in Menopause.
Feb 14, 2014
0
0